Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up
Pharmaceutical & Life Sciences News
View and Filter All Stories

Latest Stories

Texas Doctors File Second Lawsuit Over Surprise Billing Rule

The Texas Medical Association filed a second lawsuit against the Department of Health and Human Services over its regulation outlining the process for settling payment disputes between health-care providers and insurers under the No Surprises Act.

Lilly Loses Approval for Covid Therapy as Omicron Spreads (1)

US regulators said Wednesday that Eli Lilly & Co.’s monoclonal antibody treatment for Covid-19 is no longer authorized for emergency use because it’s not likely to work against infections caused by the forms of omicron that are dominant across the country.

BCBS of Massachusetts Gets First OK for Mental Health Class Deal

Blue Cross & Blue Shield of Massachusetts Inc. received preliminary federal court approval Wednesday for a class settlement in which it agreed to pay between $5,000 and $88,875 to individual families seeking coverage for their children’s mental health services.

View More

Covid-19 Vaccine: Can Your Employer Make You Take It?

As employers are making plans to return to their workplaces. How quickly they succeed will likely depend on how many of their employees get vaccinated.

Up Next

Coronavirus Is Changing the Way Lawyers Work

PFAS: The 'Forever Chemicals'